Product NDC: | 25021-114 |
Proprietary Name: | Ciprofloxacin |
Non Proprietary Name: | ciprofloxacin |
Active Ingredient(s): | 2 mg/mL & nbsp; ciprofloxacin |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 25021-114 |
Labeler Name: | Sagent Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078252 |
Marketing Category: | ANDA |
Start Marketing Date: | 20080324 |
Package NDC: | 25021-114-82 |
Package Description: | 24 POUCH in 1 CARTON (25021-114-82) > 1 BAG in 1 POUCH > 100 mL in 1 BAG |
NDC Code | 25021-114-82 |
Proprietary Name | Ciprofloxacin |
Package Description | 24 POUCH in 1 CARTON (25021-114-82) > 1 BAG in 1 POUCH > 100 mL in 1 BAG |
Product NDC | 25021-114 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ciprofloxacin |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20080324 |
Marketing Category Name | ANDA |
Labeler Name | Sagent Pharmaceuticals |
Substance Name | CIPROFLOXACIN |
Strength Number | 2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |